Bank of New York Mellon
FCSC

Bank of New York Mellon’s Fibrocell Science Inc. FCSC Stock Holding History

Bank of New York Mellon’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-6,682
Closed -$19K – 4358
2018
Q1 		$19K Buy
6,682
+305
+5% +$1K ﹤0.01% 4275
2017
Q4 		$21K Sell
6,377
-900
-12% -$7.87K ﹤0.01% 4304
2017
Q3 		$111K Buy
7,277
+900
+14% +$14.6K ﹤0.01% 3995
2017
Q2 		$127K Buy
6,377
+1
+0% +$12 ﹤0.01% 3977
2017
Q1 		$64K Sell
6,376
-1
-0% -$11 ﹤0.01% 4108
2016
Q4 		$60K Sell
6,377
-95
-1% -$1.02K ﹤0.01% 4106
2016
Q3 		$69K Sell
6,472
-1,076
-14% -$16K ﹤0.01% 4090
2016
Q2 		$130K Sell
7,548
-5,002
-40% -$156K ﹤0.01% 4002
2016
Q1 		$471K Buy
12,550
+2,136
+21% +$85.3K ﹤0.01% 3468
2015
Q4 		$711K Buy
10,414
+1
+0% +$72 ﹤0.01% 3366
2015
Q3 		$601K Sell
10,413
-891
-8% -$78.9K ﹤0.01% 3496
2015
Q2 		$893K Buy
11,304
+4,705
+71% +$317K ﹤0.01% 3403
2015
Q1 		$447K Hold
6,599
– – ﹤0.01% 3658
2014
Q4 		$257K Hold
6,599
– – ﹤0.01% 3821
2014
Q3 		$287K Hold
6,599
– – ﹤0.01% 3793
2014
Q2 		$395K Sell
6,599
-4,915
-43% -$274K ﹤0.01% 3669
2014
Q1 		$904K Buy
11,514
+748
+7% +$58K ﹤0.01% 3340
2013
Q4 		$655K Buy
10,766
+1,269
+13% +$73.9K ﹤0.01% 3481
2013
Q3 		$624K Buy
9,497
+4,848
+104% +$392K ﹤0.01% 3434
2013
Q2 		$426K Buy
+4,649
New +$384K ﹤0.01% 3557

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon's FCSC Position: Q2 2018 in Review

Bank of New York Mellon sold out of Fibrocell Science Inc. (FCSC) in Q2 2018, closing a stake of 6,682 shares — an estimated $19K sold.

Bank of New York Mellon first reported a position in FCSC in Q2 2013 and held it in 20 quarters. The position peaked at $904K in Q1 2014. 25 funds tracked by Wall St. Rank hold FCSC as of Q2 2018.

  • Bank of New York Mellon reported no remaining Fibrocell Science Inc. position as of Q2 2018 after selling out during the quarter.
  • Bank of New York Mellon sold 6,682 Fibrocell Science Inc. shares in Q2 2018, an estimated $19K.
  • Bank of New York Mellon first reported a position in Fibrocell Science Inc. in Q2 2013 and held it in 20 quarters.
  • Bank of New York Mellon's Fibrocell Science Inc. position peaked at $904K in Q1 2014.
  • 25 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q2 2018.

Based on Bank of New York Mellon's 13F filing for Q2 2018, filed 6 Aug 2018.